Combined use of non steroidal
anti-inflammatory drugs (NSAIDs)
and antidepressants was associated
with an increased risk of intracranial
haemorrhage within 30 days of
combination, according to new
research out of South Korea, and
published in the BMJ.
The retrospective nationwide
propensity score matched cohort
study scanned the Korean health
insurance database between 01 Jan
2009 and 31 Dec 2013, to examine
the data on 4,145,226 patients.
The combined use of NSAIDs with
antidepressants was 60% more
likely to cause haemorrhage and
the result was not dependent on
which class of antidepressant was
involved, the authors said.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Sep 15
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.